Skip to content

    Aarti Industries Q1 FY27 earnings call

    AARTIIND
    Chemicals·7 Aug 2026
    Management Summary

    Aarti Industries delivered strong financial growth in Q1 FY27, with significant YoY increases in revenue, EBITDA, and PAT, despite a challenging macro environment and geopolitical tensions impacting Energy business exports. The company progressed on key capacity expansions and strategic JVs, while managing raw material and currency volatility. Volume declines were observed across both Energy and Non-Energy segments QoQ, but recovery is anticipated in the coming quarters.

    Highlights

    5
    • Revenue increased by 41% Y-o-Y to ₹2,627 crores, primarily driven by higher input prices passed on to customers.

    • EBITDA grew by 79% Y-o-Y to ₹385 crores, supported by product mix optimization and monetization of low-cost inventories.

    • Profit After Tax surged by 260% Y-o-Y to ₹155 crores.

    • Completed key fuel additives capacity expansion to 360 KTPA, providing flexibility for new markets and products.

    • Augene Chemicals JV is firmly on track for commissioning in Q2 FY27, with demand tailwinds in a primary end-use application.

    Concerns

    4
    • Geopolitical tensions in the Middle East temporarily halted Energy business exports, reducing the region's revenue share from 15% to 2%.

    • Zone 4 project experienced 3-6 months of delays due to labor constraints and war-related issues, impacting ramp-up timelines for some chemistry blocks.

    • Working capital requirements expanded due to higher feedstock prices and increased export volumes, leading to higher debt levels and finance costs.

    • Demand remained soft in Q1 for Polymers, Dyes & Pigments, and Agrochemicals segments due to weak downstream demand and high raw material prices.

    Key financials

    Single quarter

    04 metrics
    1. 01Revenue₹2,627 Cr+41%YoY
    2. 02EBITDA₹385 Cr+79%YoY
    3. 03PAT₹155 Cr+2.6%YoY
    4. 04Inventory/FX Gain₹50 Cr

    Segment breakdown

    Energy Business
    -17% Volume Growth2% West Asia Revenue Share
    Non-Energy Business
    -7.0% Volume Growth
    Overall Organization
    -12% Volume Growth
    List

    Capital allocation

    5
    high confidence
    CategoryHeadline
    Capex

    ₹180 crores this quarter · ₹700 crores (FY27) planned

    Debt

    Debt disclosed

    M&A

    Augene Chemicals (JV with Superform Chemistries)

    joint venture · pending regulatory

    M&A

    Aarti Circularity (JV with Re Sustainability)

    joint venture · pending regulatory

    M&A

    Subsidiary in China

    Other · announced

    Guidance & targets

    12
    CategoryTargetPriority
    Capex
    FY27 CAPEX
    ₹700-800 crores
    High
    Capacity
    Fuel Additives Capacity
    360 KTPA
    High
    Capacity
    DCB Capacity Debottlenecking
    140 KTPA
    Medium
    Project Timeline
    Zone 4 Project Commissioning
    Phased commissioning in FY27, ramp-up over FY28 and FY29
    Medium
    Project Timeline
    PEDA Project Commercialization
    Soon
    Medium
    Project Timeline
    SABIC Backward Integration Project Commissioning
    September to October 2027
    High
    JV Timeline
    Augene Chemicals JV Commissioning
    Q2 FY27
    High
    JV Timeline
    Aarti Circularity Commissioning
    H2 FY27
    High
    JV Revenue
    Augene Chemicals JV Steady-State Revenue
    ₹300-400 crores
    Medium
    Product Portfolio
    Zone IV Products
    5-10 products by end of this year, 25-30 products by FY28
    Medium
    Volume
    Non-Energy Business Volume Recovery
    Pick up
    Medium
    Volume
    Polymer Segment Growth
    Growth
    Medium

    What to watch in Q2 FY27

    5

    Augene JV Commissioning and Ramp-up

    Next quarter
    CurrentCommissioning ongoing, first raw material sale completed
    TargetOperations and ramp-up visible in Q2 FY27

    Why it matters

    This JV is a key new capacity addition expected to deliver higher margins and contribute to PAT.

    So, within this quarter, we should start seeing operations and ramping up happening. Within the first sort of 1 to 2 years, we should be able to reach to a decent utilization level for the entire capacity that we have built.

    Risks & concerns

    8
    RiskSeverity

    Geopolitical Tensions and Supply Chain Disruptions

    Persistent geopolitical tensions in the Middle East are disrupting global supply chains, increasing freight costs, and driving inflation in crude-linked raw materials.Management acknowledged

    high

    West Asia Conflict Impact on Energy Business

    The West Asia crisis directly impacted the Energy business, temporarily halting exports to the region and reducing its revenue share from 15% to 2%.Management acknowledged

    high

    Raw Material Price Volatility

    Elevated prices of key raw materials like Benzene, Sulphur, Methanol, and Aniline impacted purchasing power and volumes in specific end applications.Management acknowledged

    high

    Zone 4 Project Delays

    The Zone 4 project experienced 3-6 months of delays due to labor constraints and war-related issues, potentially leading to a slower ramp-up for some chemistry blocks.Management acknowledged

    medium

    Demand Softness in Specific Non-Energy Segments

    Polymers, Dyes & Pigments, and Agrochemicals segments faced soft demand in Q1 FY27 due to weak downstream demand, high raw material prices, and seasonal factors.Management acknowledged

    medium

    Increased Working Capital and Debt

    Higher feedstock prices and increased export volumes led to expanded working capital requirements, consequently increasing debt levels and finance costs.Management acknowledged

    medium

    Inventory and Forex Volatility Impact

    Significant volatility in raw material prices and currency during the quarter made it difficult to precisely quantify inventory and forex gains, estimated at ₹50-60 crores.Management acknowledged

    medium

    Seasonal Weakness in Fuel Additives

    The fuel additives segment typically experiences seasonal weakness during winter months, with cracks stepping down and demand impact expected around October-December.Management acknowledged

    medium

    Q&A highlights

    8

    “In that overall capex section, the JVs are expected to remain on track. I think Augene and RESL will commission. Even the MPP, the multipurpose plant and the calcium chloride unit in Zone IV is also expected to commission now. So it should get ramped up. The other blocks, there are 5 different chemistry blocks in Zone IV, is where we are seeing the delay and which might lead to a bit slower ramp-up compared to our original anticipation that we had given in our target aspirations for FY27, '28.”

    Analyst questioned the confidence in FY28 guidance given the 6-month delay in Zone IV, highlighting potential impact on scale-up and EBITDA.

    asked by Rohit Nagraj

    3 min read6 chapters

    Detailed Narrative

    01

    Macro Environment and Q1 Performance Overview

    The first quarter of FY27 was marked by a challenging macro environment, including persistent geopolitical tensions in the Middle East, global supply chain disruption🌐s, increased freight costs, and inflation in crude-linked raw materials. Despite these headwinds, Aarti Industries reported robust financial growth, with revenue increasing by 41% Y-o-Y to ₹2,627 crores and EBITDA growing by 79% Y-o-Y to ₹385 crores. Profit After Tax saw a significant surge of 260% Y-o-Y, reaching ₹155 crores, driven by product mix optimization and monetization of low-cost inventories.

    02

    Segmental Performance and Demand Trends

    The Energy business faced direct impact from the West Asia crisis, which temporarily halted exports to the region, causing its revenue share to decline from approximately 15% to 2%. However, the company successfully redirected a significant portion of these volumes to other markets, mitigating the overall business impact, though energy volumes were down 17% QoQ. The Non-Energy business experienced mixed demand trends, with Polymers, Dyes & Pigments, and Agrochemicals segments showing softness in Q1, leading to a 7% QoQ volume decline for the segment. Pharma demand remained stable, and volume recovery is expected in Q2 for these segments.

    03

    Capacity Expansion and Project Updates

    Aarti Industries completed its key fuel additives capacity expansion, increasing it to 360 KTPA from 290 KTPA, enhancing flexibility for new markets and products. The Zone 4 project, despite a 3-6 month delay due to labor constraints and war-related issues, is progressing with phased commissioning in FY27 and ramp-up expected over FY28-FY29. The PEDA project is advancing towards commercialization, and debottlenecking of DCB capacity to 140 KTPA is also underway. The company deployed ₹180 crores in Q1 FY27 towards its FY27 CAPEX target of ₹700-800 crores, with CAPEX intensity expected to reduce significantly next year.

    04

    Strategic Initiatives and Partnerships

    The joint venture with Superform, Augene Chemicals, focused on downstream amine derivatives, is firmly on track for commissioning in Q2 FY27, with an anticipated steady-state revenue of ₹300-400 crores. Another strategic initiative, Aarti Circularity, a plastic recycling venture with Re Sustainability, is slated for commissioning in H2 FY27. The company also plans to establish a subsidiary in China to expand its global footprint, access a significant chemicals market (over 45% global share), and enhance sourcing capabilities for key raw materials.

    05

    Margin Dynamics and Volatility Management

    The quarter saw elevated prices of key raw materials, which were largely passed on to customers. EBITDA growth was supported by product mix optimization and monetization of low-cost inventories, with an estimated ₹50-60 crores attributed to inventory and forex gains. Management acknowledged significant volatility in raw material prices and currency, making precise quantification challenging. However, they expressed confidence that with volume recovery and stable pricing, the underlying business performance and true potential would become more visible, guiding the EBITDA trajectory.

    06

    Working Capital and Debt Management

    Working capital requirements expanded during the quarter, primarily driven by higher feedstock prices and increased export volumes. This expansion necessitated an increase in debt levels and finance costs to support these requirements. The company emphasized its agile strategy in dynamically balancing volume growth with spread optimization to safeguard overall profitability amidst ongoing fluctuations in feedstock costs and refining margins.

    This is an AI-generated summary of a publicly available earnings call transcript.